News
CNXU
2.220
-4.72%
-0.110
Conexeu Launches Human Collagen Initiative for Regenerative Aesthetics
TipRanks · 11h ago
Conexeu Sciences Introduces Human Collagen Program For Regenerative Aesthetics
Benzinga · 12h ago
Weekly Report: what happened at CNXU last week (1102-1106)?
Weekly Report · 1d ago
Weekly Report: what happened at CNXU last week (1026-1030)?
Weekly Report · 11/02 10:33
Weekly Report: what happened at CNXU last week (1019-1023)?
Weekly Report · 10/26 10:32
Weekly Report: what happened at CNXU last week (1012-1016)?
Weekly Report · 10/19 10:32
Conexeu Sciences Secures $5 Million Insider-Led Funding for FDA Push
TipRanks · 10/15 21:09
Press Release: Conexeu Sciences Announces $5 -2-
Dow Jones · 10/15 20:30
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 10/14 17:06
Weekly Report: what happened at CNXU last week (1005-1009)?
Weekly Report · 10/12 10:39
Conexeu Sciences Shares Rise on Advancement of Tissue Restoration Platform
Dow Jones · 10/06 19:13
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 10/06 17:05
Conexeu provides update on FDA 510 premarket notification for Ten Minute Tissue
TipRanks · 10/06 13:12
Conexeu Sciences Issues Update On Regulatory And Manufacturing Program Supporting Planned FDA 510(k) Premarket Notification For Ten Minute Tissue, Lead Wound Care Device Candidate
Benzinga · 10/06 12:35
Weekly Report: what happened at CNXU last week (0928-1002)?
Weekly Report · 10/05 10:38
Weekly Report: what happened at CNXU last week (0921-0925)?
Weekly Report · 09/28 10:32
Weekly Report: what happened at CNXU last week (0914-0918)?
Weekly Report · 09/21 10:33
Conexeu Sciences Inc. Reports Financial Results for the Quarter Ended July 31, 2026
Press release · 09/15 00:21
Weekly Report: what happened at CNXU last week (0907-0911)?
Weekly Report · 09/14 10:39
Weekly Report: what happened at CNXU last week (0831-0904)?
Weekly Report · 09/07 10:31
More
Webull provides a variety of real-time CNXU stock news. You can receive the latest news about CONEXEU SCIENCES INC through multiple platforms. This information may help you make smarter investment decisions.
About CNXU
Conexeu Sciences Inc. is an early-stage medical technology company. The Company is focused on developing regenerative biomaterials that address significant needs in wound care, dentistry, and aesthetics. The Company is focused on providing physicians with device-based solutions for healing, restoring soft tissue, and improving patient outcomes across multiple clinical settings. Its core device candidate, CXU, is a temperature-responsive ECM scaffold formulation intended to transition in-situ to a gel-like extra cellular matrix (ECM) within approximately minutes (Ten-Minute Tissue). The Company operates and manages its business in one operating segment, which is developing and commercializing novel cellular therapies for skin restoration in wound care and aesthetics.